puromycin aminonucleoside has been researched along with Diabetic Glomerulosclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartram, MP; Benzing, T; Bertsch, S; Brinkkoetter, PT; Gandhirajan, RK; Göbel, H; Grahammer, F; Hagmann, H; Höhne, M; Hoppe, AK; Huber, TB; Kann, M; Kohli, P; Kretz, O; Krüger, M; Rinschen, MM; Schermer, B; Wickström, SA | 1 |
| Hu, X; Hu, Z; Li, Y; Sui, X | 1 |
| Buckley, AF; Fields, TA; Gomez, JA; Jirka, G; Rosenberg, PB; Spurney, RF; Wang, L; Winn, MP | 1 |
| Ding, F; Ding, J; Li, B; Li, X; Zhang, X | 1 |
| Abe, M; Eguchi, M; Imasato, A; Inoki, Y; Kajiyama, H; Kondo, M; Mimura, T; Mitori, H; Moritani, H; Tanaka-Amino, K; Tomura, Y; Wada, Y | 1 |
| Ding, F; Ding, J; Ju, W; Li, S; Li, X; Tan, A | 1 |
| LANNIGAN, R | 1 |
| Sturman, JA; Trachtman, H | 1 |
1 review(s) available for puromycin aminonucleoside and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Taurine and experimental kidney disease.
Topics: Animals; Cell Division; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Kidney Diseases; Puromycin Aminonucleoside; Taurine | 1994 |
7 other study(ies) available for puromycin aminonucleoside and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
YAP-mediated mechanotransduction determines the podocyte's response to damage.
Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Animals; Cell Line; Diabetic Nephropathies; Fluorescent Antibody Technique; HEK293 Cells; Humans; Kidney Glomerulus; Male; Mechanotransduction, Cellular; Mice; Phosphoproteins; Podocytes; Proteinuria; Proteomics; Puromycin Aminonucleoside; Rats; Stress, Mechanical; Transcription Factors; YAP-Signaling Proteins | 2017 |
Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes.
Topics: Animals; Apoptosis; Cell Division; Cell Line; Diabetic Nephropathies; Kruppel-Like Transcription Factors; MAP Kinase Signaling System; Mice; Podocytes; Puromycin Aminonucleoside; Up-Regulation | 2018 |
Gq signaling causes glomerular injury by activating TRPC6.
Topics: Albuminuria; Animals; Calcineurin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Deletion; Genes, Reporter; Glomerulosclerosis, Focal Segmental; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Kidney Glomerulus; Kidney Tubules; Mice; Mice, Mutant Strains; Mice, Transgenic; NFATC Transcription Factors; Podocytes; Point Mutation; Puromycin Aminonucleoside; Recombinant Fusion Proteins; Signal Transduction; Tacrolimus; TRPC Cation Channels; TRPC6 Cation Channel | 2015 |
The Expression Profile of Complement Components in Podocytes.
Topics: Angiotensin II; Animals; Carrier Proteins; Cells, Cultured; Complement System Proteins; Diabetic Nephropathies; Disease Models, Animal; Humans; Interleukin-6; Male; Microfilament Proteins; Microscopy, Confocal; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Transcriptome; Transforming Growth Factor beta | 2016 |
Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Biomarkers; Creatinine; Diabetic Nephropathies; Doxorubicin; Kidney Diseases; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2016 |
The Prediction of Key Cytoskeleton Components Involved in Glomerular Diseases Based on a Protein-Protein Interaction Network.
Topics: Animals; Biomarkers; Cytoskeleton; Diabetic Nephropathies; Disease Models, Animal; Gene Regulatory Networks; Humans; Kidney Diseases; Kidney Glomerulus; Male; Protein Interaction Maps; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 2016 |
The production of chronic renal disease in rats by a single intravenous injection of aminonucleoside of puromycin and the effect of low dosage continuous hydrocortisone.
Topics: Animals; Anti-Bacterial Agents; Diabetic Nephropathies; Hydrocortisone; Injections, Intravenous; Kidney Failure, Chronic; Nucleosides; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Renal Insufficiency, Chronic | 1963 |